US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

EyePoint

5.01

+0.13502.77%

Post-market: 5.010.0050+0.10%19:47 EDT

Volume:4.13M

Turnover:21.03M

Market Cap:431.49M

PE:-1.33

High:5.29

Open:4.98

Low:4.96

Close:4.87

52wk High:19.11

52wk Low:3.95

Shares:86.21M

Float Shares:60.67M

Volume Ratio:0.46

T/O Rate:6.81%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.7642

EPS(LYR):-3.1667

ROE:-148.70%

ROA:-74.85%

PB:2.59

PE(LYR):-1.58

Loading ...

Overview Company News Filings

EyePoint shareholders approve 4.9 million-share increase to 2023 incentive plan

EyePoint grants inducement stock options for 39,700 shares at $12.08 each

EyePoint Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Analyst Reiterates Buy on EyePoint, Sees Durability as Key Differentiator with Price Target Maintained at $43

EyePoint’s CAPRI Phase 3 Trial Targets Long-Acting Relief in Diabetic Eye Disease

Phase 3 DURAVYU Safety Green Light Might Change The Case For Investing In EyePoint (EYPT)

Simply Wall St.

EyePoint Pharma Bets Big on DURAVYU Pivotal Data

EyePoint management joins Stifel Virtual Ophthalmology Forum fireside chat

EyePoint Announces Participation at Upcoming Investor Conferences

EyePoint grants inducement stock options for 158,100 shares at $12.35 each

EyePoint Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

EyePoint receives positive DSMC recommendation for Duravyu Phase 3 trials

EyePoint's late-stage eye drug trials to continue after safety panel review

EyePoint Pharmaceuticals Says Phase 3 Eye Drug Trials Clear Safety Review

MT Newswires Live

EyePoint Advances DURAVYU Phase 3 Wet AMD Program

EyePoint Inc - Dsmc Recommends Phase 3 Duravyu Wet Amd Trials Continue With No Modifications

THOMSON REUTERS

EyePoint Inc - Interim Phase 3 Data Shows Continued Favorable Safety Profile for Duravyu

THOMSON REUTERS

EyePoint Announces Third Consecutive Positive Dsmc Recommendation for Phase 3 Wet Amd Trials for Duravyu™, Building Confidence Ahead of Mid-2026 Topline Data

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/EYPT/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"EYPT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EYPT\",,,,,undefined,":{"symbol":"EYPT","market":"US","secType":"STK","nameCN":"EyePoint","latestPrice":5.005,"timestamp":1787688000000,"preClose":4.87,"halted":0,"volume":4133632,"hourTrading":{"tag":"盘后","latestPrice":5.01,"preClose":5.005,"latestTime":"19:47 EDT","volume":96132,"amount":481355.6582,"timestamp":1787701653055,"change":0.005,"changeRate":0.000999,"amplitude":0.01982},"delay":0,"changeRate":0.027720739219712482,"floatShares":60674399,"shares":86212138,"eps":-3.764176,"marketStatus":"Not Yet Opened","change":0.135,"latestTime":"08-25 16:00:00 EDT","open":4.98,"high":5.285,"low":4.96,"amount":21031353.308415998,"amplitude":0.066735,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.764176,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":4.87,"preHourTrading":{"tag":"盘前","latestPrice":4.9219,"preClose":4.87,"latestTime":"09:29 EDT","volume":19641,"amount":97220.082414,"timestamp":1787664587058,"change":0.0519,"changeRate":0.010657,"amplitude":0.034908},"postHourTrading":{"tag":"盘后","latestPrice":5.01,"preClose":5.005,"latestTime":"19:47 EDT","volume":96132,"amount":481355.6582,"timestamp":1787701653055,"change":0.005,"changeRate":0.000999,"amplitude":0.01982},"volumeRatio":0.461557,"impliedVol":1.3967,"impliedVolPercentile":0.728},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EYPT\",,,,,undefined,":{"symbol":"EYPT","floatShares":60674399,"roa":"-74.85%","roe":"-148.70%","lyrEps":-3.166673,"volumeRatio":0.461557,"shares":86212138,"dividePrice":0,"high":5.285,"amplitude":0.066735,"preClose":4.87,"low":4.96,"week52Low":3.95,"pbRate":"2.59","psRate":"154.77","week52High":19.11,"institutionHeld":0.6415,"latestPrice":5.005,"eps":-3.764176,"divideRate":0,"volume":4133632,"delay":0,"ttmEps":-3.764176,"open":4.98,"prevYearClose":18.27,"prevWeekClose":5.32,"prevMonthClose":12.25,"prevQuarterClose":14.3,"fiveDayClose":5.47,"twentyDayClose":11.96,"sixtyDayClose":13.58},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EYPT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"EYPT","fiscalQuarterEnding":"2026/06","expectedEps":-0.92,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"pre","actualEps":-1.09},{"market":"US","date":"2026-05-06","symbol":"EYPT","fiscalQuarterEnding":"2026/03","expectedEps":-0.79,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"pre","actualEps":-0.99},{"market":"US","date":"2026-03-04","symbol":"EYPT","fiscalQuarterEnding":"2025/12","expectedEps":-0.78,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772600400000,"reportTimeType":"pre","actualEps":-0.81},{"market":"US","date":"2025-11-05","symbol":"EYPT","fiscalQuarterEnding":"2025/09","expectedEps":-0.77,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":-0.85},{"market":"US","date":"2025-08-06","symbol":"EYPT","fiscalQuarterEnding":"2025/06","expectedEps":-0.67,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"pre","actualEps":-0.85}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EYPT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EYPT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3077,"buy":0.3077,"hold":0.3846,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3077,"analysts":13,"updateTime":1787284800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EYPT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EYPT","date":"2026-08-24","current":-1.32964,"percent":0.94621,"low":-17.174537,"twenty":-7.129027,"median":-4.853357,"eighty":-2.791301,"high":-0.764844,"avg":-5.324275,"sd":3.010572,"marketCap":458648574},"quantilePoints":[{"date":"2021-08-27","current":-6.964065,"twenty":-4.472799,"median":-2.743614,"eighty":-1.930259,"marketCap":289426531},{"date":"2021-09-03","current":-7.628628,"twenty":-4.546098,"median":-2.75544,"eighty":-1.941719,"marketCap":317045763},{"date":"2021-09-10","current":-7.102515,"twenty":-4.61979,"median":-2.759953,"eighty":-1.956547,"marketCap":295180538},{"date":"2021-09-17","current":-7.642473,"twenty":-4.694611,"median":-2.760901,"eighty":-1.971028,"marketCap":317621164},{"date":"2021-09-24","current":-8.113205,"twenty":-4.731269,"median":-2.77201,"eighty":-1.988007,"marketCap":337184786},{"date":"2021-10-01","current":-7.760156,"twenty":-4.841039,"median":-2.78384,"eighty":-1.998647,"marketCap":322512069},{"date":"2021-10-08","current":-7.137128,"twenty":-4.919907,"median":-2.790917,"eighty":-2.015619,"marketCap":296619040},{"date":"2021-10-15","current":-7.919374,"twenty":-4.938321,"median":-2.79725,"eighty":-2.019761,"marketCap":329129177},{"date":"2021-10-22","current":-8.313958,"twenty":-4.971427,"median":-2.804116,"eighty":-2.02816,"marketCap":345528096},{"date":"2021-10-29","current":-7.940141,"twenty":-5.098544,"median":-2.833605,"eighty":-2.028584,"marketCap":329992278},{"date":"2021-11-05","current":-7.455146,"twenty":-5.185586,"median":-2.834547,"eighty":-2.038548,"marketCap":405962535},{"date":"2021-11-12","current":-7.40231,"twenty":-5.288363,"median":-2.838221,"eighty":-2.041297,"marketCap":403085408},{"date":"2021-11-19","current":-10.730609,"twenty":-5.348044,"median":-2.838221,"eighty":-2.041297,"marketCap":584324577},{"date":"2021-11-26","current":-10.288687,"twenty":-5.475735,"median":-2.838221,"eighty":-2.041297,"marketCap":560260166},{"date":"2021-12-03","current":-9.043837,"twenty":-5.543465,"median":-2.838221,"eighty":-2.041297,"marketCap":492473092},{"date":"2021-12-10","current":-9.050061,"twenty":-5.631762,"median":-2.838221,"eighty":-2.041297,"marketCap":492812027},{"date":"2021-12-17","current":-8.502327,"twenty":-5.718585,"median":-2.850463,"eighty":-2.041297,"marketCap":462985715},{"date":"2021-12-23","current":-8.43386,"twenty":-5.736973,"median":-2.850463,"eighty":-2.041297,"marketCap":459257426},{"date":"2021-12-31","current":-7.618483,"twenty":-5.783171,"median":-2.850463,"eighty":-2.041297,"marketCap":414856892},{"date":"2022-01-07","current":-8.782418,"twenty":-5.864553,"median":-2.850463,"eighty":-2.041984,"marketCap":478237807},{"date":"2022-01-14","current":-6.180681,"twenty":-5.916223,"median":-2.850463,"eighty":-2.041984,"marketCap":336562822},{"date":"2022-01-21","current":-5.439995,"twenty":-5.918806,"median":-2.850463,"eighty":-2.041984,"marketCap":296229513},{"date":"2022-01-28","current":-5.40265,"twenty":-5.918806,"median":-2.850463,"eighty":-2.041984,"marketCap":294195901},{"date":"2022-02-04","current":-5.813451,"twenty":-5.931903,"median":-2.850463,"eighty":-2.041984,"marketCap":316565635},{"date":"2022-02-11","current":-6.224251,"twenty":-5.976705,"median":-2.850463,"eighty":-2.041984,"marketCap":338935370},{"date":"2022-02-18","current":-5.639172,"twenty":-6.042095,"median":-2.850463,"eighty":-2.041984,"marketCap":307075445},{"date":"2022-02-25","current":-5.801002,"twenty":-6.042095,"median":-2.850463,"eighty":-2.041984,"marketCap":315887764},{"date":"2022-03-04","current":-6.637487,"twenty":-6.076834,"median":-2.850463,"eighty":-2.041984,"marketCap":387742063},{"date":"2022-03-11","current":-7.652837,"twenty":-6.099766,"median":-2.850463,"eighty":-2.041984,"marketCap":447055753},{"date":"2022-03-18","current":-7.447927,"twenty":-6.135388,"median":-2.850467,"eighty":-2.041984,"marketCap":435085578},{"date":"2022-03-25","current":-7.401305,"twenty":-6.148738,"median":-2.850472,"eighty":-2.041984,"marketCap":432362038},{"date":"2022-04-01","current":-7.080776,"twenty":-6.15825,"median":-2.850472,"eighty":-2.041984,"marketCap":413637698},{"date":"2022-04-08","current":-6.96422,"twenty":-6.180751,"median":-2.853843,"eighty":-2.041984,"marketCap":406828847},{"date":"2022-04-14","current":-7.395477,"twenty":-6.19313,"median":-2.860806,"eighty":-2.041984,"marketCap":432021595},{"date":"2022-04-22","current":-7.290577,"twenty":-6.210376,"median":-2.860806,"eighty":-2.041984,"marketCap":425893630},{"date":"2022-04-29","current":-6.585969,"twenty":-6.244501,"median":-2.860806,"eighty":-2.041984,"marketCap":384732546},{"date":"2022-05-06","current":-5.646366,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":378944534},{"date":"2022-05-13","current":-5.017301,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":336726095},{"date":"2022-05-20","current":-4.824523,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":323788187},{"date":"2022-05-27","current":-4.915839,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":329916670},{"date":"2022-06-03","current":-4.59116,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":308126508},{"date":"2022-06-10","current":-4.017899,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":269653253},{"date":"2022-06-17","current":-4.007753,"twenty":-6.277913,"median":-2.87084,"eighty":-2.041984,"marketCap":268972311},{"date":"2022-06-24","current":-3.678001,"twenty":-6.277913,"median":-2.869838,"eighty":-2.041297,"marketCap":246841678},{"date":"2022-07-01","current":-3.931656,"twenty":-6.277913,"median":-2.869838,"eighty":-2.041297,"marketCap":263865242},{"date":"2022-07-08","current":-4.185311,"twenty":-6.277913,"median":-2.869838,"eighty":-2.041297,"marketCap":280888806},{"date":"2022-07-15","current":-5.027447,"twenty":-6.277913,"median":-2.871843,"eighty":-2.041297,"marketCap":337407038},{"date":"2022-07-22","current":-5.428222,"twenty":-6.277913,"median":-2.876614,"eighty":-2.041297,"marketCap":364304269},{"date":"2022-07-29","current":-4.631745,"twenty":-6.277913,"median":-2.897069,"eighty":-2.041297,"marketCap":310850278},{"date":"2022-08-05","current":-4.689345,"twenty":-6.277913,"median":-2.902765,"eighty":-2.041297,"marketCap":358777096},{"date":"2022-08-12","current":-4.947637,"twenty":-6.277913,"median":-2.918529,"eighty":-2.041297,"marketCap":378538797},{"date":"2022-08-19","current":-4.680438,"twenty":-6.277913,"median":-2.955067,"eighty":-2.041297,"marketCap":358095658},{"date":"2022-08-26","current":-4.578012,"twenty":-6.277913,"median":-2.981219,"eighty":-2.041297,"marketCap":350259121},{"date":"2022-09-02","current":-4.123773,"twenty":-6.277913,"median":-3.01561,"eighty":-2.041297,"marketCap":315505784},{"date":"2022-09-09","current":-3.990174,"twenty":-6.277913,"median":-3.047288,"eighty":-2.041297,"marketCap":305284215},{"date":"2022-09-16","current":-3.638389,"twenty":-6.277913,"median":-3.074739,"eighty":-2.041297,"marketCap":278369506},{"date":"2022-09-23","current":-3.206414,"twenty":-6.277913,"median":-3.090207,"eighty":-2.041297,"marketCap":245319516},{"date":"2022-09-30","current":-3.522602,"twenty":-6.277913,"median":-3.110217,"eighty":-2.041297,"marketCap":269510746},{"date":"2022-10-07","current":-2.743265,"twenty":-6.277913,"median":-3.117347,"eighty":-2.041297,"marketCap":209884474},{"date":"2022-10-14","current":-2.493877,"twenty":-6.277913,"median":-3.117347,"eighty":-2.041297,"marketCap":190804068},{"date":"2022-10-21","current":-2.596305,"twenty":-6.277913,"median":-3.117347,"eighty":-2.041297,"marketCap":198640663},{"date":"2022-10-28","current":-2.444891,"twenty":-6.277913,"median":-3.117347,"eighty":-2.041297,"marketCap":187056130},{"date":"2022-11-04","current":-2.291539,"twenty":-6.277913,"median":-3.117347,"eighty":-2.041297,"marketCap":179276232},{"date":"2022-11-11","current":-2.017077,"twenty":-6.277913,"median":-3.117347,"eighty":-2.037196,"marketCap":157803984},{"date":"2022-11-18","current":-1.568353,"twenty":-6.277913,"median":-3.117347,"eighty":-2.028584,"marketCap":122698562},{"date":"2022-11-25","current":-1.44637,"twenty":-6.277913,"median":-3.117347,"eighty":-2.028584,"marketCap":113155340},{"date":"2022-12-02","current":-1.476866,"twenty":-6.277913,"median":-3.117347,"eighty":-2.020056,"marketCap":115541146},{"date":"2022-12-09","current":-1.267752,"twenty":-6.277913,"median":-3.117347,"eighty":-2.016865,"marketCap":99181337},{"date":"2022-12-16","current":-1.076065,"twenty":-6.277913,"median":-3.117347,"eighty":-2.005257,"marketCap":84184846},{"date":"2022-12-23","current":-1.259039,"twenty":-6.277913,"median":-3.117347,"eighty":-1.998555,"marketCap":98499679},{"date":"2022-12-30","current":-1.524788,"twenty":-6.277913,"median":-3.117347,"eighty":-1.991624,"marketCap":119290269},{"date":"2023-01-06","current":-1.420231,"twenty":-6.277913,"median":-3.117347,"eighty":-1.975507,"marketCap":111110364},{"date":"2023-01-13","current":-2.195695,"twenty":-6.277913,"median":-3.117347,"eighty":-1.963772,"marketCap":171777987},{"date":"2023-01-20","current":-1.834102,"twenty":-6.277913,"median":-3.117347,"eighty":-1.951722,"marketCap":143489152},{"date":"2023-01-27","current":-2.060642,"twenty":-6.277913,"median":-3.110217,"eighty":-1.94839,"marketCap":161212277},{"date":"2023-02-03","current":-2.021433,"twenty":-6.277913,"median":-3.099225,"eighty":-1.94839,"marketCap":158144813},{"date":"2023-02-10","current":-1.768754,"twenty":-6.277913,"median":-3.099225,"eighty":-1.939746,"marketCap":138376712},{"date":"2023-02-17","current":-1.503005,"twenty":-6.277913,"median":-3.099225,"eighty":-1.928219,"marketCap":117586122},{"date":"2023-02-24","current":-1.428944,"twenty":-6.277913,"median":-3.099225,"eighty":-1.918005,"marketCap":111792023},{"date":"2023-03-03","current":-1.086611,"twenty":-6.277913,"median":-3.099225,"eighty":-1.903097,"marketCap":111110364},{"date":"2023-03-10","current":-0.811808,"twenty":-6.277913,"median":-3.099225,"eighty":-1.876527,"marketCap":83010660},{"date":"2023-03-17","current":-0.788326,"twenty":-6.277913,"median":-3.099225,"eighty":-1.862926,"marketCap":80609526},{"date":"2023-03-24","current":-0.764844,"twenty":-6.277913,"median":-3.099225,"eighty":-1.844212,"marketCap":78208391},{"date":"2023-03-31","current":-0.986247,"twenty":-6.277913,"median":-3.098122,"eighty":-1.833959,"marketCap":100847662},{"date":"2023-04-06","current":-1.014761,"twenty":-6.277913,"median":-3.099225,"eighty":-1.830785,"marketCap":103763326},{"date":"2023-04-14","current":-1.298223,"twenty":-6.277913,"median":-3.096321,"eighty":-1.818062,"marketCap":132748453},{"date":"2023-04-21","current":-1.905402,"twenty":-6.277913,"median":-3.074739,"eighty":-1.806764,"marketCap":194834939},{"date":"2023-04-28","current":-2.101645,"twenty":-6.277913,"median":-3.057645,"eighty":-1.806764,"marketCap":214901566},{"date":"2023-05-05","current":-2.270232,"twenty":-6.25452,"median":-3.0294,"eighty":-1.806764,"marketCap":232567058},{"date":"2023-05-12","current":-2.136295,"twenty":-6.25452,"median":-3.000653,"eighty":-1.806764,"marketCap":218846287},{"date":"2023-05-19","current":-2.052584,"twenty":-6.25452,"median":-2.918529,"eighty":-1.806764,"marketCap":210270806},{"date":"2023-05-26","current":-1.985615,"twenty":-6.25452,"median":-2.89721,"eighty":-1.806764,"marketCap":203410421},{"date":"2023-06-02","current":-1.995661,"twenty":-6.25452,"median":-2.88216,"eighty":-1.806764,"marketCap":204439478},{"date":"2023-06-09","current":-2.035842,"twenty":-6.25452,"median":-2.865856,"eighty":-1.806764,"marketCap":208555710},{"date":"2023-06-16","current":-2.27358,"twenty":-6.25452,"median":-2.836384,"eighty":-1.806764,"marketCap":232910077},{"date":"2023-06-23","current":-2.08272,"twenty":-6.25953,"median":-2.815898,"eighty":-1.806567,"marketCap":213357979},{"date":"2023-06-30","current":-2.752405,"twenty":-6.264539,"median":-2.79725,"eighty":-1.80637,"marketCap":281961831},{"date":"2023-07-07","current":-2.882993,"twenty":-6.219784,"median":-2.79725,"eighty":-1.80637,"marketCap":295339582},{"date":"2023-07-14","current":-3.63304,"twenty":-6.19313,"median":-2.79725,"eighty":-1.80637,"marketCap":372175897},{"date":"2023-07-21","current":-3.95114,"twenty":-6.180681,"median":-2.79725,"eighty":-1.80637,"marketCap":404762726},{"date":"2023-07-28","current":-3.515845,"twenty":-6.158749,"median":-2.79725,"eighty":-1.80637,"marketCap":360170223},{"date":"2023-08-04","current":-4.05643,"twenty":-6.148902,"median":-2.79725,"eighty":-1.8052,"marketCap":429803132},{"date":"2023-08-11","current":-4.629056,"twenty":-6.137112,"median":-2.79725,"eighty":-1.8052,"marketCap":490476296},{"date":"2023-08-18","current":-4.361614,"twenty":-6.101011,"median":-2.79725,"eighty":-1.8052,"marketCap":462139221},{"date":"2023-08-25","current":-3.800317,"twenty":-6.098107,"median":-2.79725,"eighty":-1.8052,"marketCap":402666346},{"date":"2023-09-01","current":-3.272036,"twenty":-6.067271,"median":-2.79725,"eighty":-1.8052,"marketCap":346691876},{"date":"2023-09-08","current":-3.321563,"twenty":-6.026618,"median":-2.79725,"eighty":-1.8052,"marketCap":351939482},{"date":"2023-09-15","current":-3.631927,"twenty":-5.954331,"median":-2.79725,"eighty":-1.8052,"marketCap":384824484},{"date":"2023-09-22","current":-2.756963,"twenty":-5.954331,"median":-2.790917,"eighty":-1.8052,"marketCap":292116767},{"date":"2023-09-29","current":-2.641402,"twenty":-5.954331,"median":-2.778602,"eighty":-1.8052,"marketCap":279872352},{"date":"2023-10-06","current":-2.793282,"twenty":-5.954331,"median":-2.768311,"eighty":-1.8052,"marketCap":295965012},{"date":"2023-10-13","current":-2.674419,"twenty":-5.954331,"median":-2.767265,"eighty":-1.8052,"marketCap":283370756},{"date":"2023-10-20","current":-2.476314,"twenty":-5.954331,"median":-2.759953,"eighty":-1.8052,"marketCap":262380330},{"date":"2023-10-27","current":-2.039467,"twenty":-5.962331,"median":-2.756201,"eighty":-1.801691,"marketCap":216093723},{"date":"2023-11-03","current":-2.570254,"twenty":-5.962331,"median":-2.752288,"eighty":-1.801691,"marketCap":257405759},{"date":"2023-11-10","current":-2.326979,"twenty":-5.962331,"median":-2.743614,"eighty":-1.801691,"marketCap":233042251},{"date":"2023-11-17","current":-2.178898,"twenty":-5.962331,"median":-2.743614,"eighty":-1.801691,"marketCap":218212289},{"date":"2023-11-24","current":-2.164795,"twenty":-5.962331,"median":-2.743614,"eighty":-1.801691,"marketCap":216799912},{"date":"2023-12-01","current":-2.203578,"twenty":-5.962331,"median":-2.74344,"eighty":-1.801691,"marketCap":220683950},{"date":"2023-12-08","current":-9.955568,"twenty":-6.049293,"median":-2.752172,"eighty":-1.802861,"marketCap":997030242},{"date":"2023-12-15","current":-9.574831,"twenty":-6.092369,"median":-2.75544,"eighty":-1.802861,"marketCap":958900191},{"date":"2023-12-22","current":-9.77225,"twenty":-6.109725,"median":-2.759953,"eighty":-1.802861,"marketCap":978671329},{"date":"2023-12-29","current":-11.074277,"twenty":-6.140987,"median":-2.764196,"eighty":-1.806567,"marketCap":1109066691},{"date":"2024-01-05","current":-9.368011,"twenty":-6.14956,"median":-2.778602,"eighty":-1.80637,"marketCap":938187570},{"date":"2024-01-12","current":-9.570131,"twenty":-6.168114,"median":-2.793282,"eighty":-1.80637,"marketCap":958429449},{"date":"2024-01-19","current":-10.745245,"twenty":-6.181032,"median":-2.79725,"eighty":-1.8052,"marketCap":1076114794},{"date":"2024-01-26","current":-11.704138,"twenty":-6.200408,"median":-2.804116,"eighty":-1.80637,"marketCap":1172146036},{"date":"2024-02-02","current":-13.401003,"twenty":-6.254636,"median":-2.834547,"eighty":-1.80637,"marketCap":1342083674},{"date":"2024-02-09","current":-13.687731,"twenty":-6.30708,"median":-2.853195,"eighty":-1.80637,"marketCap":1370798898},{"date":"2024-02-16","current":-13.668929,"twenty":-6.37565,"median":-2.853195,"eighty":-1.80637,"marketCap":1368915933},{"date":"2024-02-23","current":-12.268193,"twenty":-6.417185,"median":-2.853195,"eighty":-1.80637,"marketCap":1228635001},{"date":"2024-03-01","current":-12.789944,"twenty":-6.540499,"median":-2.856467,"eighty":-1.806567,"marketCap":1280887294},{"date":"2024-03-08","current":-16.829528,"twenty":-6.600791,"median":-2.864789,"eighty":-1.806567,"marketCap":1191446432},{"date":"2024-03-15","current":-15.302231,"twenty":-6.677113,"median":-2.871843,"eighty":-1.806567,"marketCap":1083321418},{"date":"2024-03-22","current":-16.48474,"twenty":-6.761591,"median":-2.887382,"eighty":-1.806567,"marketCap":1167037148},{"date":"2024-03-28","current":-14.647627,"twenty":-6.81781,"median":-2.892586,"eighty":-1.806567,"marketCap":1036978781},{"date":"2024-04-05","current":-14.18307,"twenty":-6.857077,"median":-2.918529,"eighty":-1.80637,"marketCap":1004090458},{"date":"2024-04-12","current":-16.111686,"twenty":-6.901762,"median":-3.019122,"eighty":-1.80637,"marketCap":1140626828},{"date":"2024-04-19","current":-12.317803,"twenty":-6.964065,"median":-3.050414,"eighty":-1.807354,"marketCap":872038860},{"date":"2024-04-26","current":-11.374611,"twenty":-6.977129,"median":-3.092915,"eighty":-1.807507,"marketCap":805265598},{"date":"2024-05-03","current":-14.669933,"twenty":-6.99966,"median":-3.108194,"eighty":-1.807507,"marketCap":1038557911},{"date":"2024-05-10","current":-8.362276,"twenty":-7.014797,"median":-3.172728,"eighty":-1.811775,"marketCap":659909031},{"date":"2024-05-17","current":-8.263275,"twenty":-7.045704,"median":-3.193664,"eighty":-1.811775,"marketCap":652096375},{"date":"2024-05-24","current":-7.332667,"twenty":-7.080776,"median":-3.232956,"eighty":-1.817369,"marketCap":578657406},{"date":"2024-05-31","current":-7.095065,"twenty":-7.101547,"median":-3.286694,"eighty":-1.83021,"marketCap":559907031},{"date":"2024-06-07","current":-6.118256,"twenty":-7.101547,"median":-3.330137,"eighty":-1.834973,"marketCap":482822156},{"date":"2024-06-14","current":-6.131456,"twenty":-7.102515,"median":-3.412645,"eighty":-1.845001,"marketCap":483863843},{"date":"2024-06-21","current":-5.385649,"twenty":-7.102515,"median":-3.462472,"eighty":-1.863418,"marketCap":425008500},{"date":"2024-06-28","current":-5.775053,"twenty":-7.102515,"median":-3.473443,"eighty":-1.885785,"marketCap":455738281},{"date":"2024-07-05","current":-5.689252,"twenty":-7.102515,"median":-3.509148,"eighty":-1.903349,"marketCap":448967312},{"date":"2024-07-12","current":-6.54066,"twenty":-7.102515,"median":-3.561832,"eighty":-1.919277,"marketCap":516156156},{"date":"2024-07-15","current":-6.817862,"twenty":-7.102515,"median":-3.561832,"eighty":-1.920686,"marketCap":538031593},{"date":"2024-08-02","current":-6.025855,"twenty":-7.124873,"median":-3.608452,"eighty":-1.963141,"marketCap":475530343},{"date":"2024-08-09","current":-5.503143,"twenty":-7.124873,"median":-3.632484,"eighty":-1.96681,"marketCap":477788393},{"date":"2024-08-16","current":-5.054645,"twenty":-7.124873,"median":-3.645064,"eighty":-1.980482,"marketCap":438849322},{"date":"2024-08-23","current":-5.547781,"twenty":-7.124873,"median":-3.698817,"eighty":-1.980482,"marketCap":481663890},{"date":"2024-08-30","current":-5.375183,"twenty":-7.124873,"median":-3.810182,"eighty":-1.980482,"marketCap":466678791},{"date":"2024-09-06","current":-4.968346,"twenty":-7.124873,"median":-3.83418,"eighty":-1.980482,"marketCap":431356772},{"date":"2024-09-13","current":-5.473811,"twenty":-7.124873,"median":-3.903238,"eighty":-1.980482,"marketCap":475241704},{"date":"2024-09-20","current":-5.658737,"twenty":-7.124873,"median":-3.951544,"eighty":-1.980482,"marketCap":491297167},{"date":"2024-09-27","current":-4.97451,"twenty":-7.124873,"median":-3.986281,"eighty":-1.980482,"marketCap":431891954},{"date":"2024-10-04","current":-5.159436,"twenty":-7.124873,"median":-4.012982,"eighty":-1.980482,"marketCap":447947417},{"date":"2024-10-11","current":-5.079302,"twenty":-7.124873,"median":-4.052753,"eighty":-1.980482,"marketCap":440990050},{"date":"2024-10-18","current":-6.873084,"twenty":-7.124873,"median":-4.083441,"eighty":-1.980482,"marketCap":596728041},{"date":"2024-10-25","current":-5.892976,"twenty":-7.124873,"median":-4.137591,"eighty":-1.980482,"marketCap":511634087},{"date":"2024-10-31","current":-8.74412,"twenty":-7.137898,"median":-4.196959,"eighty":-1.980482,"marketCap":759173235},{"date":"2024-11-08","current":-7.626837,"twenty":-7.20923,"median":-4.361614,"eighty":-1.97961,"marketCap":789911501},{"date":"2024-11-15","current":-7.106109,"twenty":-7.272765,"median":-4.416406,"eighty":-1.97961,"marketCap":735979669},{"date":"2024-11-22","current":-5.656435,"twenty":-7.272765,"median":-4.456923,"eighty":-1.97961,"marketCap":585837010},{"date":"2024-11-29","current":-5.995144,"twenty":-7.272765,"median":-4.545502,"eighty":-1.97961,"marketCap":620917070},{"date":"2024-12-06","current":-5.527726,"twenty":-7.272765,"median":-4.586087,"eighty":-1.97961,"marketCap":572506587},{"date":"2024-12-13","current":-5.378694,"twenty":-7.272765,"median":-4.621598,"eighty":-1.97961,"marketCap":557071360},{"date":"2024-12-20","current":-4.823212,"twenty":-7.272765,"median":-4.654737,"eighty":-1.97961,"marketCap":499540061},{"date":"2024-12-27","current":-5.134824,"twenty":-7.272765,"median":-4.680438,"eighty":-1.97961,"marketCap":531813717},{"date":"2025-01-03","current":-5.439662,"twenty":-7.272765,"median":-4.688488,"eighty":-1.97961,"marketCap":563385771},{"date":"2025-01-10","current":-6.171273,"twenty":-7.274134,"median":-4.721011,"eighty":-1.978739,"marketCap":639158702},{"date":"2025-01-17","current":-4.924825,"twenty":-7.274134,"median":-4.757117,"eighty":-1.978739,"marketCap":510064079},{"date":"2025-01-24","current":-5.974822,"twenty":-7.274134,"median":-4.81202,"eighty":-1.978739,"marketCap":618812267},{"date":"2025-01-31","current":-5.45321,"twenty":-7.274134,"median":-4.825842,"eighty":-1.978739,"marketCap":564788974},{"date":"2025-02-07","current":-4.484503,"twenty":-7.274134,"median":-4.853805,"eighty":-1.978739,"marketCap":464460001},{"date":"2025-02-14","current":-4.274504,"twenty":-7.274134,"median":-4.853805,"eighty":-1.978739,"marketCap":442710363},{"date":"2025-02-21","current":-4.301601,"twenty":-7.274134,"median":-4.853805,"eighty":-1.978739,"marketCap":445516768},{"date":"2025-02-28","current":-4.22031,"twenty":-7.274134,"median":-4.853805,"eighty":-1.978739,"marketCap":437097553},{"date":"2025-03-07","current":-3.581647,"twenty":-7.275504,"median":-4.857083,"eighty":-1.977868,"marketCap":468730143},{"date":"2025-03-14","current":-3.586899,"twenty":-7.275504,"median":-4.857083,"eighty":-1.977868,"marketCap":469417430},{"date":"2025-03-21","current":-3.203526,"twenty":-7.275504,"median":-4.857083,"eighty":-1.982224,"marketCap":419245436},{"date":"2025-03-28","current":-3.103744,"twenty":-7.275504,"median":-4.857083,"eighty":-1.982224,"marketCap":406186971},{"date":"2025-04-04","current":-2.620589,"twenty":-7.275504,"median":-4.857083,"eighty":-1.986581,"marketCap":342956512},{"date":"2025-04-11","current":-2.520807,"twenty":-7.274134,"median":-4.853805,"eighty":-1.998664,"marketCap":329898048},{"date":"2025-04-17","current":-2.914683,"twenty":-7.274134,"median":-4.853805,"eighty":-2.003697,"marketCap":381444618},{"date":"2025-04-25","current":-3.4346,"twenty":-7.275504,"median":-4.857083,"eighty":-2.020056,"marketCap":449486090},{"date":"2025-05-02","current":-3.744449,"twenty":-7.275504,"median":-4.857083,"eighty":-2.020056,"marketCap":490036058},{"date":"2025-05-09","current":-2.859698,"twenty":-7.275504,"median":-4.857083,"eighty":-2.021433,"marketCap":419749277},{"date":"2025-05-16","current":-2.681567,"twenty":-7.275504,"median":-4.857083,"eighty":-2.025797,"marketCap":393603129},{"date":"2025-05-23","current":-2.625311,"twenty":-7.275504,"median":-4.857083,"eighty":-2.025797,"marketCap":385345721},{"date":"2025-05-30","current":-3.380087,"twenty":-7.275504,"median":-4.857083,"eighty":-2.025797,"marketCap":496132616},{"date":"2025-06-06","current":-3.867645,"twenty":-7.275504,"median":-4.857083,"eighty":-2.029337,"marketCap":567696822},{"date":"2025-06-13","current":-4.153616,"twenty":-7.275504,"median":-4.857083,"eighty":-2.030146,"marketCap":609671980},{"date":"2025-06-20","current":-4.181745,"twenty":-7.275519,"median":-4.85959,"eighty":-2.030146,"marketCap":613800685},{"date":"2025-06-27","current":-4.861513,"twenty":-7.275519,"median":-4.869751,"eighty":-2.049961,"marketCap":713577702},{"date":"2025-07-03","current":-4.556789,"twenty":-7.275519,"median":-4.869751,"eighty":-2.092939,"marketCap":668850073},{"date":"2025-07-11","current":-5.184989,"twenty":-7.275519,"median":-4.878866,"eighty":-2.11162,"marketCap":761057800},{"date":"2025-07-18","current":-4.828696,"twenty":-7.275519,"median":-4.878866,"eighty":-2.147002,"marketCap":708760880},{"date":"2025-07-25","current":-4.917769,"twenty":-7.275519,"median":-4.892425,"eighty":-2.165118,"marketCap":721835110},{"date":"2025-08-01","current":-4.60367,"twenty":-7.275519,"median":-4.894961,"eighty":-2.173127,"marketCap":675731247},{"date":"2025-08-08","current":-3.951022,"twenty":-7.275519,"median":-4.894961,"eighty":-2.187675,"marketCap":692934181},{"date":"2025-08-15","current":-4.264217,"twenty":-7.275519,"median":-4.894961,"eighty":-2.213274,"marketCap":747862561},{"date":"2025-08-22","current":-4.558978,"twenty":-7.275519,"median":-4.894961,"eighty":-2.238916,"marketCap":799558130},{"date":"2025-08-29","current":-4.558978,"twenty":-7.275519,"median":-4.894961,"eighty":-2.269562,"marketCap":799558130},{"date":"2025-09-05","current":-4.669022,"twenty":-7.275534,"median":-4.895546,"eighty":-2.300854,"marketCap":818857809},{"date":"2025-09-12","current":-5.238895,"twenty":-7.275519,"median":-4.91446,"eighty":-2.329404,"marketCap":918802575},{"date":"2025-09-19","current":-5.407891,"twenty":-7.275519,"median":-4.923075,"eighty":-2.352075,"marketCap":948441368},{"date":"2025-09-26","current":-5.183872,"twenty":-7.275519,"median":-4.932745,"eighty":-2.419563,"marketCap":909152735},{"date":"2025-10-03","current":-5.305707,"twenty":-7.275519,"median":-4.942197,"eighty":-2.463236,"marketCap":930520237},{"date":"2025-10-10","current":-5.49239,"twenty":-7.275519,"median":-4.956209,"eighty":-2.494254,"marketCap":963260764},{"date":"2025-10-17","current":-4.539327,"twenty":-7.275519,"median":-4.96602,"eighty":-2.56263,"marketCap":796111758},{"date":"2025-10-24","current":-4.519677,"twenty":-7.275519,"median":-4.96602,"eighty":-2.574573,"marketCap":792665387},{"date":"2025-10-31","current":-5.619401,"twenty":-7.275519,"median":-5.020563,"eighty":-2.612621,"marketCap":985536169},{"date":"2025-11-07","current":-4.346629,"twenty":-7.275519,"median":-5.033717,"eighty":-2.637757,"marketCap":894327662},{"date":"2025-11-14","current":-4.631211,"twenty":-7.275519,"median":-5.033717,"eighty":-2.650995,"marketCap":952880902},{"date":"2025-11-21","current":-5.488246,"twenty":-7.275519,"median":-5.054089,"eighty":-2.672098,"marketCap":1129217680},{"date":"2025-11-28","current":-5.96706,"twenty":-7.275519,"median":-5.068604,"eighty":-2.688416,"marketCap":1227734472},{"date":"2025-12-05","current":-6.727528,"twenty":-7.275519,"median":-5.094712,"eighty":-2.710416,"marketCap":1384202318},{"date":"2025-12-12","current":-6.478062,"twenty":-7.275519,"median":-5.147222,"eighty":-2.740497,"marketCap":1332874242},{"date":"2025-12-19","current":-6.864332,"twenty":-7.275519,"median":-5.165076,"eighty":-2.756051,"marketCap":1412349973},{"date":"2025-12-26","current":-7.347169,"twenty":-7.289324,"median":-5.172773,"eighty":-2.793921,"marketCap":1511694637},{"date":"2026-01-02","current":-7.351192,"twenty":-7.324613,"median":-5.18443,"eighty":-2.826121,"marketCap":1512522509},{"date":"2026-01-09","current":-6.872379,"twenty":-7.324613,"median":-5.207453,"eighty":-2.826121,"marketCap":1414005717},{"date":"2026-01-16","current":-6.373447,"twenty":-7.324613,"median":-5.221197,"eighty":-2.826121,"marketCap":1311349564},{"date":"2026-01-23","current":-6.572618,"twenty":-7.324613,"median":-5.24479,"eighty":-2.826121,"marketCap":1352329238},{"date":"2026-01-30","current":-5.934871,"twenty":-7.324613,"median":-5.267112,"eighty":-2.826121,"marketCap":1221111495},{"date":"2026-02-06","current":-5.122095,"twenty":-7.286659,"median":-5.256581,"eighty":-2.826121,"marketCap":1053881310},{"date":"2026-02-13","current":-5.234757,"twenty":-7.238055,"median":-5.24837,"eighty":-2.826121,"marketCap":1077061732},{"date":"2026-02-20","current":-5.914752,"twenty":-7.198521,"median":-5.24479,"eighty":-2.826121,"marketCap":1216972134},{"date":"2026-02-27","current":-7.186223,"twenty":-7.149753,"median":-5.24479,"eighty":-2.826121,"marketCap":1478579749},{"date":"2026-03-06","current":-5.668547,"twenty":-7.140441,"median":-5.24479,"eighty":-2.826121,"marketCap":1314887532},{"date":"2026-03-13","current":-5.046302,"twenty":-7.140441,"median":-5.24086,"eighty":-2.826121,"marketCap":1170550258},{"date":"2026-03-20","current":-4.959979,"twenty":-7.13159,"median":-5.215152,"eighty":-2.826121,"marketCap":1150526590},{"date":"2026-03-27","current":-4.697413,"twenty":-7.13159,"median":-5.207022,"eighty":-2.826121,"marketCap":1089621267},{"date":"2026-04-02","current":-4.683026,"twenty":-7.13159,"median":-5.185686,"eighty":-2.826121,"marketCap":1086283989},{"date":"2026-04-10","current":-5.118238,"twenty":-7.13159,"median":-5.172773,"eighty":-2.826121,"marketCap":1187236648},{"date":"2026-04-17","current":-5.326852,"twenty":-7.13159,"median":-5.171072,"eighty":-2.826121,"marketCap":1235627179},{"date":"2026-04-24","current":-4.977963,"twenty":-7.13159,"median":-5.160679,"eighty":-2.826121,"marketCap":1154698188},{"date":"2026-05-01","current":-4.747768,"twenty":-7.13159,"median":-5.151767,"eighty":-2.826121,"marketCap":1101301740},{"date":"2026-05-08","current":-4.137326,"twenty":-7.13159,"median":-5.128459,"eighty":-2.826121,"marketCap":1123693672},{"date":"2026-05-15","current":-4.087124,"twenty":-7.13159,"median":-5.100254,"eighty":-2.826121,"marketCap":1110058785},{"date":"2026-05-22","current":-3.945124,"twenty":-7.13159,"median":-5.073284,"eighty":-2.826121,"marketCap":1071491788},{"date":"2026-05-29","current":-4.167385,"twenty":-7.132974,"median":-5.060809,"eighty":-2.825942,"marketCap":1131857523},{"date":"2026-06-05","current":-3.784603,"twenty":-7.13159,"median":-5.043144,"eighty":-2.826121,"marketCap":1027894313},{"date":"2026-06-12","current":-3.85869,"twenty":-7.13159,"median":-5.01676,"eighty":-2.826121,"marketCap":1048016225},{"date":"2026-06-18","current":-4.059341,"twenty":-7.13159,"median":-4.976237,"eighty":-2.826121,"marketCap":1102513068},{"date":"2026-06-26","current":-4.232211,"twenty":-7.132974,"median":-4.96547,"eighty":-2.825942,"marketCap":1149464195},{"date":"2026-07-02","current":-4.073233,"twenty":-7.132974,"median":-4.952785,"eighty":-2.825942,"marketCap":1106285927},{"date":"2026-07-10","current":-4.581036,"twenty":-7.132974,"median":-4.94121,"eighty":-2.825942,"marketCap":1244204862},{"date":"2026-07-17","current":-4.025385,"twenty":-7.132974,"median":-4.938731,"eighty":-2.825942,"marketCap":1093290525},{"date":"2026-07-24","current":-3.849429,"twenty":-7.132974,"median":-4.917769,"eighty":-2.825942,"marketCap":1045500986},{"date":"2026-07-31","current":-3.96982,"twenty":-7.134359,"median":-4.902522,"eighty":-2.825763,"marketCap":1078199092},{"date":"2026-08-07","current":-3.507935,"twenty":-7.134359,"median":-4.891056,"eighty":-2.825763,"marketCap":1075683853},{"date":"2026-08-14","current":-3.789878,"twenty":-7.129027,"median":-4.880588,"eighty":-2.825763,"marketCap":1162139620},{"date":"2026-08-21","current":-1.5182,"twenty":-7.129027,"median":-4.856954,"eighty":-2.793602,"marketCap":465545545},{"date":"2026-08-24","current":-1.495709,"twenty":-7.129027,"median":-4.853357,"eighty":-2.791301,"marketCap":458648574}],"updateTime":1787690394986},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EYPT\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2645802944","title":"EyePoint shareholders approve 4.9 million-share increase to 2023 incentive plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2645802944","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645802944?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:05","pubTimestamp":1782126356,"startTime":"0","endTime":"0","summary":"EyePoint held its annual shareholder meeting on June 18, 2026.Shareholders adopted an amendment to the 2023 long-term incentive plan, increasing authorized share issuance by 4,900,000 shares.Shareholders ratified Deloitte & Touche as independent registered public accounting firm for fiscal 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EyePoint Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 22, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL75hygB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EYPT","LU0889565916.HKD","BK4588","LU0320765992.SGD","BK4007","BK4585","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643591207","title":"EyePoint grants inducement stock options for 39,700 shares at $12.08 each","url":"https://stock-news.laohu8.com/highlight/detail?id=2643591207","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643591207?lang=en_us&edition=fundamental","pubTime":"2026-06-16 19:01","pubTimestamp":1781607663,"startTime":"0","endTime":"0","summary":"EyePoint granted inducement stock options covering 39,700 shares to three new employees on June 15, 2026.Options carry an exercise price of USD 12.08 per share.Ten-year term; vesting over four years with 25% after one year, then monthly over the next three years.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL2j4Rl9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","SG9999014013.SGD","LU0314104364.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","BK4588","SG9999014039.USD","BK4112","BK4007","IE00BKPKM429.USD","SG9999014005.SGD","IE00BN0W2V16.EUR","LU0109394709.USD","EYPT","LU2095319765.USD","BK4585","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU0889565916.HKD","LU2210149790.SGD","IE00B64PRP62.GBP","NDAQ","LU0320765992.SGD","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643678759","title":"EyePoint Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2643678759","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643678759?lang=en_us&edition=fundamental","pubTime":"2026-06-16 19:00","pubTimestamp":1781607602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nTUA7MG4CY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4585","LU0889565916.HKD","LU0320765992.SGD","EYPT","LU0109394709.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643375907","title":"EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2643375907","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643375907?lang=en_us&edition=fundamental","pubTime":"2026-06-16 19:00","pubTimestamp":1781607600,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., June  16, 2026  (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/16/3312402/0/en/EyePoint-Reports-Inducement-Grants-Under-NASDAQ-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","JEPQ","PSQ","GPIQ","BK4588","LU0320765992.SGD","IYW","QQQY","QQQJ","QQQE","QQQA","ONEQ","FTEC","QDTE","NDX","TQQQ","MNQmain","BK4585","SQQQ","NVIW.SI","EYPT","NQmain","TQQY",".IXIC","LU0109394709.USD","QLD","BK4007","TECS","QID","QYLG","QQQM","QQQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642230211","title":"Analyst Reiterates Buy on EyePoint, Sees Durability as Key Differentiator with Price Target Maintained at $43","url":"https://stock-news.laohu8.com/highlight/detail?id=2642230211","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642230211?lang=en_us&edition=fundamental","pubTime":"2026-06-12 07:45","pubTimestamp":1781221517,"startTime":"0","endTime":"0","summary":"Analyst Debanjana Chatterjee of JonesTrading maintained a Buy rating on EyePoint Pharmaceuticals, retaining the price target of $43.00. Debanjana C...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-eyepoint-sees-durability-as-key-differentiator-with-price-target-maintained-at-43-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-eyepoint-sees-durability-as-key-differentiator-with-price-target-maintained-at-43-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EYPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640856381","title":"EyePoint’s CAPRI Phase 3 Trial Targets Long-Acting Relief in Diabetic Eye Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2640856381","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640856381?lang=en_us&edition=fundamental","pubTime":"2026-06-04 00:33","pubTimestamp":1780504382,"startTime":"0","endTime":"0","summary":"Eyepoint Pharma ($EYPT) announced an update on their ongoing clinical study. The CAPRI phase 3 trial from EyePoint Pharmaceuticals, Inc. tests a ne...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eyepoints-capri-phase-3-trial-targets-long-acting-relief-in-diabetic-eye-disease?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eyepoints-capri-phase-3-trial-targets-long-acting-relief-in-diabetic-eye-disease?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","BK4588","LU0109394709.USD","BK4585","BK4007","LU0889565916.HKD","EYPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637365690","title":"Phase 3 DURAVYU Safety Green Light Might Change The Case For Investing In EyePoint (EYPT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637365690","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637365690?lang=en_us&edition=fundamental","pubTime":"2026-05-22 07:33","pubTimestamp":1779406420,"startTime":"0","endTime":"0","summary":"Earlier this month, EyePoint Pharmaceuticals reported that an independent safety committee completed its third review of the pivotal Phase 3 DURAVYU wet AMD trials and advised that the LUGANO and LUCIA studies proceed as planned, with no protocol changes and a safety profile consistent with prior studies in over 190 patients.\nThis progress, with all treated patients having received at least a second six‑month DURAVYU dose and over 35% reaching a third, underscores how close the program is to...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eypt/eyepoint/news/phase-3-duravyu-safety-green-light-might-change-the-case-for","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eypt/eyepoint/news/phase-3-duravyu-safety-green-light-might-change-the-case-for","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","LU0320765992.SGD","LU0109394709.USD","LU0889565916.HKD","BK4007","EYPT","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636892362","title":"EyePoint Pharma Bets Big on DURAVYU Pivotal Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2636892362","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636892362?lang=en_us&edition=fundamental","pubTime":"2026-05-20 11:18","pubTimestamp":1779247106,"startTime":"0","endTime":"0","summary":"Eyepoint Pharma (($EYPT)) has held its Q1 earnings call. Read on for the main highlights of the call. EyePoint Pharmaceuticals’ latest earnings cal...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eyepoint-pharma-bets-big-on-duravyu-pivotal-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eyepoint-pharma-bets-big-on-duravyu-pivotal-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","LU0889565916.HKD","BK4007","BK4588","BK4585","EYPT","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636476858","title":"EyePoint management joins Stifel Virtual Ophthalmology Forum fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2636476858","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636476858?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:05","pubTimestamp":1779188706,"startTime":"0","endTime":"0","summary":"EyePoint management is scheduled to take part in a fireside chat at the Stifel 2026 Virtual Ophthalmology Forum on May 26, 2026 at 9:00 a.m. ET.Participation is also set for a fireside chat at the Jefferies Global Healthcare Conference on June 3, 2026 at 4:55 p.m. ET.A further fireside chat is slated for the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026 at 11:20 a.m. ET.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL1tR3TT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","IE00B19Z3581.USD","LU1894683264.USD","LU0096364046.USD","LU0106831901.USD","EYPT","LU1804176565.USD","LU1868836757.USD","LU1894683348.USD","SG9999014005.SGD","IE00BN0W2T93.GBP","LU0742534661.SGD","LU2237443978.SGD","IE00B19Z3B42.SGD","LU1868837300.USD","IE00BFXG1179.USD","IE00BKPKM429.USD","LU1791807156.HKD","LU1868837136.USD","LU0889565916.HKD","LU1868836914.USD","IE0034235188.USD","BK4588","LU2237443382.USD","LU0942090050.USD","LU2237443465.HKD","LU2237443622.USD","IE00BSNM7G36.USD","LU0251142724.SGD","LU2471134879.HKD","IE0004086264.USD","LU2471134796.USD","LU2750360997.AUD","SG9999014039.USD","LU0314104364.USD","LU0320765992.SGD","BK4533","LU2471134952.CNY","IE0004091025.USD","NDAQ","LU0048573561.USD","GSX","BK4516","LU2471134523.USD","BK4552","LU0251131958.USD","LU1868836591.USD","IE00BN0W2V16.EUR","SF","LU1668664300.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636858153","title":"EyePoint Announces Participation at Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2636858153","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636858153?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:00","pubTimestamp":1779188400,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., May  19, 2026  (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/19/3297309/0/en/EyePoint-Announces-Participation-at-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","EYPT","BK4588","BK4007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636133027","title":"EyePoint grants inducement stock options for 158,100 shares at $12.35 each","url":"https://stock-news.laohu8.com/highlight/detail?id=2636133027","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636133027?lang=en_us&edition=fundamental","pubTime":"2026-05-18 19:00","pubTimestamp":1779102016,"startTime":"0","endTime":"0","summary":"EyePoint granted inducement stock options covering 158,100 shares to eight new employees, with grants dated May 15, 2026.The options carry an exercise price of $12.35 per share, matching the stock’s closing price that day.The awards have a 10-year term, with 25% vesting on the first anniversary of the grant date, then monthly vesting over the next three years.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nNDL9qSFnw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","EYPT","LU0320765992.SGD","BK4007","LU2210149790.SGD","LU0889565916.HKD","LU2210150020.SGD","LU2095319765.USD","IE00BGHQF748.EUR","SG9999014021.USD","BK4588","NDAQ","BK4585","IE00BKPKM429.USD","IE00B64PRP62.GBP","LU0314104364.USD","SG9999014039.USD","LU0109394709.USD","SG9999014013.SGD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636027979","title":"EyePoint Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2636027979","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636027979?lang=en_us&edition=fundamental","pubTime":"2026-05-18 19:00","pubTimestamp":1779102002,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nTUABL9DHC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","EYPT","BK4007","LU0889565916.HKD","BK4585","LU0109394709.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636027420","title":"EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2636027420","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636027420?lang=en_us&edition=fundamental","pubTime":"2026-05-18 19:00","pubTimestamp":1779102000,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., May  18, 2026  (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with seriou","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/18/3296488/0/en/EyePoint-Reports-Inducement-Grants-Under-NASDAQ-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","NDX","MNQmain","LU0109394709.USD","IYW","EYPT","BK4007","JEPQ","TQQY","QQQJ","LU0889565916.HKD","QQQ","QQQM","QID","QDTE","SQQQ","QYLG","TECS","QQQY","TQQQ","QQQE",".IXIC","BK4585","BK4588","NVIW.SI","NQmain","PSQ","QLD","ONEQ","FTEC","QQQA","GPIQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635374633","title":"EyePoint receives positive DSMC recommendation for Duravyu Phase 3 trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2635374633","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635374633?lang=en_us&edition=fundamental","pubTime":"2026-05-14 22:31","pubTimestamp":1778769085,"startTime":"0","endTime":"0","summary":"EyePoint (EYPT) announced the independent data safety monitoring committee completed its third scheduled review of the company’s pivotal Phase 3 pr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eyepoint-receives-positive-dsmc-recommendation-for-duravyu-phase-3-trials-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eyepoint-receives-positive-dsmc-recommendation-for-duravyu-phase-3-trials-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","LU0889565916.HKD","BK4588","BK4585","BK4007","LU0320765992.SGD","DSMC","EYPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635174547","title":"EyePoint's late-stage eye drug trials to continue after safety panel review","url":"https://stock-news.laohu8.com/highlight/detail?id=2635174547","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635174547?lang=en_us&edition=fundamental","pubTime":"2026-05-14 20:35","pubTimestamp":1778762109,"startTime":"0","endTime":"0","summary":"May 14  - EyePoint EYPT.O said on Thursday an independent safety committee found no new concerns in two late-stage trials of its experimental eye disease drug Duravyu and recommended the studies continue unchanged.The independent safety committee completed its third scheduled review and recommended the studies continue without protocol changes. EyePoint said topline data from the first study remain on track for mid-2026, with results from the second expected shortly after.The studies have enrolled more than 900 patients and are evaluating Duravyu against Regeneron's REGN.O blockbuster eye drug, Eylea. EyePoint said interim safety data showed a continued favorable safety profile, consistent with results seen in more than 190 patients across four earlier trials.EyePoint said the main goal of the studies is to show Duravyu works about as well as Eylea in maintaining patients' vision at weeks 52 and 56.The drug is also being tested in late-stage studies for diabetic macular edema, with dat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nL4N41R15Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1974910355.USD","REGN","LU0053666078.USD","LU0889565916.HKD","LU0109394709.USD","LU2362541273.HKD","OCUL","LU0114720955.EUR","BK4007","LU2237438978.USD","LU2106854487.HKD","LU0823434583.USD","BK4588","LU0320765992.SGD","LU2023250504.SGD","LU2468319806.SGD","LU0823416689.USD","LU0823434740.USD","LU0289739699.SGD","BK4585","EYPT","LU2089984988.USD","LU1917777945.USD","LU0058720904.USD","BK4139","LU2362540622.SGD","LU2362541513.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635712469","title":"EyePoint Pharmaceuticals Says Phase 3 Eye Drug Trials Clear Safety Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2635712469","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635712469?lang=en_us&edition=fundamental","pubTime":"2026-05-14 20:12","pubTimestamp":1778760773,"startTime":"0","endTime":"0","summary":"EyePoint Pharmaceuticals  said Thursday that an independent safety committee recommended that late-stage trials of its experimental drug, Duravyu, for wet age-related macular degeneration continue without changes after completing a scheduled safety review.The company said interim masked safety data continued to show a favorable safety profile for the drug, consistent with results seen in more than 190 patients across four completed studies.The trials are comparing Duravyu, administered every six months, with aflibercept in more than 900 patients with the condition to demonstrate that it is not inferior to aflibercept in preserving vision at Weeks 52 and 56, the company added.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0320765992.SGD","EYPT","LU0889565916.HKD","BK4007","BK4585","BK4588","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635714500","title":"EyePoint Advances DURAVYU Phase 3 Wet AMD Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2635714500","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635714500?lang=en_us&edition=fundamental","pubTime":"2026-05-14 19:34","pubTimestamp":1778758464,"startTime":"0","endTime":"0","summary":"EyePoint Pharmaceuticals ( ($EYPT) ) just unveiled an announcement. On May 14, 2026, EyePoint reported that an independent Data Safety Monitoring C...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eyepoint-advances-duravyu-phase-3-wet-amd-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eyepoint-advances-duravyu-phase-3-wet-amd-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","LU1861559042.SGD","IE0009356076.USD","BK4141","LU0127658192.USD","LU2860962120.EUR","AMDU","BK4614","LU0889565916.HKD","AMUU","LU0823421333.USD","IE0004445239.USD","LU2360106780.USD","BK4575","BK4566","LU0642271901.SGD","LU0823434740.USD","LU2264538146.SGD","AMDL","LU1316542783.SGD","LU0198837287.USD","LU2054465674.USD","LU1803068979.SGD","AMDD","LU0251132253.USD","LU1064131342.USD","LU0889565833.HKD","LU1989764664.SGD","LU1988902786.USD","LU1880398554.USD","SG9999001424.SGD","LU1923623000.USD","BK4554","BK4512","LU0056508442.USD","LU0823421416.USD","IE00B5949003.HKD","LU2250418816.HKD","LU0823434583.USD","LU1951198990.SGD","LU1303367103.USD","BK4532","IE00BMPRXN33.USD","LU0109394709.USD","LU2089985449.USD","AMYY","AMDY","LU1880398471.USD","LU1852331112.SGD","LU0719512351.SGD","BK4585","LU2098885051.SGD","BK4543","BK4007","DAMD","BK4529","LU1861558580.USD","EYPT","BK4573","LU1242518857.USD","BK4612","LU2242649171.HKD","IE00BMPRXR70.SGD","LU0081259029.USD","LU0109392836.USD","LU0979878070.USD","LU2458330169.SGD","LU0320765992.SGD","AMDS","LU2931357623.SGD","LU2458330243.SGD","LU1951200564.SGD","LU0048584097.USD","LU0082616367.USD","AMDG","LU0274383776.USD","AMDW","LU1242518931.SGD","LU2355687059.USD","BK4605","BK4588","LU0390134368.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635719558","title":"EyePoint Inc - Dsmc Recommends Phase 3 Duravyu Wet Amd Trials Continue With No Modifications","url":"https://stock-news.laohu8.com/highlight/detail?id=2635719558","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635719558?lang=en_us&edition=fundamental","pubTime":"2026-05-14 19:00","pubTimestamp":1778756403,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nTUA8NG1MZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","BK4585","LU0109394709.USD","BK4007","EYPT","BK4588","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635719349","title":"EyePoint Inc - Interim Phase 3 Data Shows Continued Favorable Safety Profile for Duravyu","url":"https://stock-news.laohu8.com/highlight/detail?id=2635719349","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635719349?lang=en_us&edition=fundamental","pubTime":"2026-05-14 19:00","pubTimestamp":1778756403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nTUA8NG1MZ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0109394709.USD","BK4585","BK4007","LU0889565916.HKD","BK4588","LU0320765992.SGD","EYPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635369719","title":"EyePoint Announces Third Consecutive Positive Dsmc Recommendation for Phase 3 Wet Amd Trials for Duravyu™, Building Confidence Ahead of Mid-2026 Topline Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2635369719","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635369719?lang=en_us&edition=fundamental","pubTime":"2026-05-14 19:00","pubTimestamp":1778756403,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nTUA8NG1MZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","EYPT","BK4588","BK4007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":191,"code":"91000000","status":"200"}]}}